Abstract
Multiple myeloma (MM) is a clonal plasma cell tumor originating from a post-mitotic lymphoid B-cell lineage. Bortezomib (BTZ), a first-generation prot......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
